Midcourse correction to a clinical trial when the event rate is underestimated: the Look AHEAD (Action for Health in Diabetes) Study

Composite Outcomes in Cardiovascular Research: A Survey of Randomized Trials

(2013) Eric Lim et al.   ANNALS OF INTERNAL MEDICINE

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

(2011) Colin Baigent et al.   LANCET

Paired Comparison of Observed and Expected Coronary Heart Disease Rates over 12 Years from the Atherosclerosis Risk In Communities Study

(2010) Nina P. Paynter et al.   ANNALS OF EPIDEMIOLOGY

Body-Mass Index and Mortality among 1.46 Million White Adults

(2010) Amy Berrington de Gonzalez et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of Registered and Published Primary Outcomes in Randomized Controlled Trials

(2009) Sylvain Mathieu   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial

(2008) Robert M. Califf et al.   AMERICAN HEART JOURNAL